Dayson Friaca Moreira

Title: Innovations by Dayson Friaca Moreira

Introduction

Dayson Friaca Moreira is an accomplished inventor based in Duarte, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of compounds and compositions that have potential applications in cancer treatment and autoimmune diseases. With a total of 2 patents, his work is paving the way for innovative therapeutic methods.

Latest Patents

Dayson Friaca Moreira's latest patents focus on isolated compounds that include phosphorothioated oligodeoxynucleotide (ODN) sequences. These sequences are conjugated to short-activating RNA (saRNA) or antisense oligonucleotide sequences (ASO). The patents detail methods of treatment for cancer and autoimmune diseases, which can be applied with or without stimulating an immune response. Additionally, they describe methods for immune stimulation, activating CEBPA, and reducing the activity of the STAT transcription factor using the disclosed compounds or compositions.

Career Highlights

Dayson is currently associated with City of Hope, a prominent research and treatment center. His work at this institution allows him to collaborate with leading experts in the field, further enhancing the impact of his innovations.

Collaborations

Some of his notable coworkers include Marcin Tomasz Kortylewski and Piotr Marek Swiderski. Their collaborative efforts contribute to the advancement of research in biotechnology and therapeutic applications.

Conclusion

Dayson Friaca Moreira's innovative work in biotechnology exemplifies the potential of scientific research to address critical health challenges. His patents and collaborations are significant steps toward developing effective treatments for serious diseases.